A new study paves the way for the development of next generation therapeutics for the prevention and treatment of Clostridioides difficile infection (CDI), the most frequent cause of healthcare-acquired gastrointestinal infections and death in developed countries.
from Top Health News -- ScienceDaily https://ift.tt/3wHxbwD
No comments:
Post a Comment